Clinical Trials Logo

Clinical Trial Summary

This study tries to prove that Cicatricell cream significantly reduces scarring with better wound appearance as compared to no treatment.


Clinical Trial Description

At 1st post operative follow up visit, surgical incision(s) will be assessed for healing, after the sutures/staples/steri-strips are removed. To be included in the study the incision must be 5cm or greater. And bilateral incisions as in bilateral mastectomy can be included. The incisions will be divided into two sections, using an imaginary line between top and bottom, or left and right. One side of the imaginary line will have cicatricell cream applied 2 times a day for a minimum of 8 weeks and a maximum 6months. The other side of the imaginary line will remain untreated. In the case of a bilateral incision, as in bilateral breast mastectomy or AAA incisions in the groins, the cream will be applied to one entire incision and the 2nd incision will be untreated. The incision(s) will be its own control group. At the end of the treatment phase the incision(s) will be assessed again to compare the healing. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03020420
Study type Interventional
Source University of Toledo
Contact
Status Completed
Phase N/A
Start date March 2015
Completion date December 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT00872638 - The Effect of Wound Edge Eversion on Cosmesis N/A
Completed NCT01835405 - LiquiBand Versus Dermabond Versus Sutures for Closure of Surgical Wounds N/A
Completed NCT00557947 - Prineo (Dermabond Protape) Versus Sutures for Full-thickness Surgical Incisions Phase 4
Completed NCT00890578 - HISTOACRYL: A Study of Its Efficacy in Final Scar Formation Phase 4